Access the full text.
Sign up today, get DeepDyve free for 14 days.
Lewis Lanier, S. O'Fallon, C. Somoza, Joseph Phillips, P. Linsley, K. Okumura, Daisuke Ito, M. Azuma (1995)
CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.Journal of immunology, 154 1
C. King, R. Stupi, N. Craighead, C. June, G. Thyphronitis (1995)
CD28 activation promotes Th2 subset differentiation by human CD4+ cellsEuropean Journal of Immunology, 25
W. Ho, M. Cooke, C. Goodnow, Mark Davis (1994)
Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cellsThe Journal of Experimental Medicine, 179
S. Klaus, L. Pinchuk, H. Ochs, C. Law, W. Fanslow, R. Armitage, E. Clark (1994)
Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.Journal of immunology, 152 12
A. Shahinian, K. Pfeffer, Kelvin Lee, T. Kündig, K. Kishihara, A. Wakeham, K. Kawai, P. Ohashi, C. Thompson, T. Mak (1993)
Differential T cell costimulatory requirements in CD28-deficient mice.Science, 261 5121
L. Boise, M. González‐García, C. Postema, Liyun Ding, T. Lindsten, L. Turka, X. Mao, G. Núñez, C. Thompson (1993)
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 74
Serge Barcy, Martine Wettendorff, Oberdan Leo, J. Urbain, Mariana Kruger, Jan Ceuppens, M. Boer (1995)
FcR cross-linking on monocytes results in impaired T cell stimulatory capacity.International immunology, 7 2
Yan Wu, Yong Guo, Yang Liu (1993)
A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7The Journal of Experimental Medicine, 178
Yang Liu, Yang Liu, P. Linsley, P. Linsley (1992)
Costimulation of T-cell growth.Current opinion in immunology, 4 3
P. Bretscher, M. Cohn (1970)
A Theory of Self-Nonself DiscriminationScience, 169
K. Hathcock, G. László, C. Pucillo, P. Linsley, R. Hodes (1994)
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and functionThe Journal of Experimental Medicine, 180
M. Azuma, D. Ito, H. Yagita, K. Okumura, J. Phillips, L. Lanier, C. Somoza (1993)
B70 antigen is a second ligand for CTLA-4 and CD28Nature, 366
P. Lucas, I. Negishi, K. Nakayama, L. Fields, D. Loh (1995)
Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response.Journal of immunology, 154 11
G. Freeman, F. Borriello, R. Hodes, Hans Reiser, K. Hathcock, Glória László, Andrew McKnight, Jinny Kim, Lina Du, David Lombard, Gary Gray, Lee Nadler, Arlene Sharpe (1993)
Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.Science, 262 5135
R. Seder, R. Germain, P. Linsley, W. Paul (1994)
CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma productionThe Journal of Experimental Medicine, 179
Lakshmi Ramarathinam, Madalyn Castle, Yan Wu, Yang Liu (1994)
T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cellsThe Journal of Experimental Medicine, 179
T. Watts, N. Alaverdi, W. Wade, P. Linsley (1993)
Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction.Journal of immunology, 150 6
M. Sethna, L. Parijs, A. Sharpe, A. Abbas, G. Freeman (1994)
A negative regulatory function of B7 revealed in B7-1 transgenic mice.Immunity, 1 5
L. Turka, Peter Linsley, Hua Lin, William Brady, J. Leiden, Ru Wei, M. Gibson, Xianxian Zheng, S. Myrdal, D. Gordon (1992)
T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.Proceedings of the National Academy of Sciences of the United States of America, 89 22
P. Linsley, W. Brady, L. Grosmaire, A. Aruffo, N. Damle, J. Ledbetter (1991)
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulationThe Journal of Experimental Medicine, 173
B. Blazar, P. Taylor, P. Linsley, D. Vallera (1994)
In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice.Blood, 83 12
C. Thompson, T. Lindsten, J. Ledbetter, S. Kunkel, H. Young, S. Emerson, J. Leiden, C. June (1989)
CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.Proceedings of the National Academy of Sciences of the United States of America, 86 4
K. Lafferty, R. Gill (1993)
The maintenance of self‐toleranceImmunology and Cell Biology, 71
P. Linsley, J. Bradshaw, Mark Urnes, L. Grosmaire, J. Ledbetter (1993)
CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling.Journal of immunology, 150 8 Pt 1
W. Lesslauer, H. Gmünder (1986)
Biochemical characterization of the 9.3 antigens of human T-cells: simultaneous expression of disulfide-bonded 90-kilodalton dimers and free subunits at the cell surface.Molecular immunology, 23 3
R. Stack, D. Lenschow, Gary Gray, J. Bluestone, Frank Fitch (1994)
IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2.Journal of immunology, 152 12
Elizabeth Kearney, Theresa Walunas, Robert Karr, Phillip Morton, Dennis Loh, J. Bluestone, M. Jenkins (1995)
Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.Journal of immunology, 155 3
D. Lenschow, G. Su, L. Zuckerman, N. Nabavi, C. Jellis, G. Gray, J. Miller, J. Bluestone (1993)
Expression and functional significance of an additional ligand for CTLA-4.Proceedings of the National Academy of Sciences of the United States of America, 90 23
O. Kanagawa, B. Vaupel, S. Korsmeyer, J. Russell (1995)
Apoptotic death of lymphocytes in murine acquired immunodeficiency syndrome: Involvement of Fas‐Fas ligand interactionEuropean Journal of Immunology, 25
G. Freeman, G. Gray, C. Gimmi, D. Lombard, Liangji Zhou, M. White, J. Fingeroth, J. Gribben, L. Nadler (1991)
Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7The Journal of Experimental Medicine, 174
J. Gross, T. John, J. Allison (1990)
The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression.Journal of immunology, 144 8
D. Harlan, H. Hengartner, Mark Huang, Yuan‐Hsu Kang, R. Abe, R. Moreadith, Hanspeter Pircheri, G. Gray, Pamela Ohashiii, G. Freeman, L. Nadler, C. June, P. Aichele (1994)
Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness.Proceedings of the National Academy of Sciences of the United States of America, 91
T. Walunas, D. Lenschow, C. Bakker, P. Linsley, G. Freeman, J. Green, C. Thompson, C. Thompson, J. Bluestone (1994)
CTLA-4 can function as a negative regulator of T cell activation.Immunity, 1 5
K. Hathcock, Glória László, H. Dickler, Jeff Bradshaw, P. Linsley, R. Hodes (1993)
Identification of an alternative CTLA-4 ligand costimulatory for T cell activation.Science, 262 5135
T. Lindsten, Kelvin Lee, E. Harris, B. Petryniak, N. Craighead, P. Reynolds, D. Lombard, G. Freeman, L. Nadler, G. Gray (1993)
Characterization of CTLA-4 structure and expression on human T cells.Journal of immunology, 151 7
Anne Cross, Thomas Girard, Karen Giacoletto, Robert Evans, R. Keeling, RobinF Lin, John Trotter, Robert Karr (1995)
Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.The Journal of clinical investigation, 95 6
L. Boise, A. Minn, P. Noel, C. June, M. Accavitti, T. Lindsten, C. Thompson (1995)
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL.Immunity, 3 1
J. Green, P. Noel, A. Sperling, T. Walunas, G. Gray, J. Bluestone, C. Thompson (1994)
Absence of B7-dependent responses in CD28-deficient mice.Immunity, 1 6
G. John, Gribben, G. Freeman, V. Boussiotis, Paul, RENNERTt, Cindy JELLISt, E. Greenfieldt, Michael Barber, Vincent Restivo, X. Ke, Gary GRAYt, L. Nadler (1995)
CTLA4 mediates antigen-specific apoptosis of human T cells.Proceedings of the National Academy of Sciences of the United States of America, 92 3
S. Baskar, S. Ostrand-Rosenberg, N. Nabavi, Lee Nadler, G. Freeman, L. Glimcher (1993)
Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.Proceedings of the National Academy of Sciences of the United States of America, 90 12
C. Gimmi, G. Freeman, J. Gribben, K. Sugita, A. Freedman, C. Morimoto, L. Nadler (1991)
B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.Proceedings of the National Academy of Sciences of the United States of America, 88
F. Harding, J. Mcarthur, J. Gross, D. Raulet, J. Allison (1992)
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clonesNature, 356
M. Azuma, M. Cayabyab, D. Buck, J. Phillips, L. Lanier (1992)
CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytesThe Journal of Experimental Medicine, 175
E. Ranheim, T. Kipps (1993)
Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signalThe Journal of Experimental Medicine, 177
F. Ronchese, Barbara Hausmann, S. Hubele, Peter Lane (1994)
Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivoThe Journal of Experimental Medicine, 179
P. Linsley, J. Ledbetter (1993)
The role of the CD28 receptor during T cell responses to antigen.Annual review of immunology, 11
F. Symington, W. Brady, P. Linsley (1993)
Expression and function of B7 on human epidermal Langerhans cells.Journal of immunology, 150 4
K. Inaba, M. Witmer-Pack, M. Inaba, K. Hathcock, Hiraki Sakuta, M. Azuma, H. Yagita, K. Okumura, P. Linsley, S. Ikehara, S. Muramatsu, R. Hodes, R. Steinman (1994)
The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitroThe Journal of Experimental Medicine, 180
D. Hockenbery, G. Núñez, C. Milliman, R. Schreiber, S. Korsmeyer (1990)
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 348
D. Lenschow, Y. Zeng, Thistlethwaite, A. Montag, W. Brady, M. Gibson, P. Linsley, J. Bluestone (1992)
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.Science, 257 5071
Chaoyuan Chen, A. Gault, Lijing Shen, N. Nabavi (1994)
Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule.Journal of immunology, 152 10
D. Corry, Steven Reiner, P. Linsley, R. Locksley (1994)
Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis.Journal of immunology, 153 9
P. Linsley, Philip Wallace, Jennifer Johnson, Marylou Gibson, JoAnne Greene, Jeffrey Ledbetter, Cherry Singh, Mark Tepper (1992)
Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule.Science, 257 5071
B. Finck, P. Linsley, D. Wofsy (1994)
Treatment of murine lupus with CTLA4Ig.Science, 265 5176
Lieping Chen, S. Ashe, W. Brady, I. Hellström, K. Hellström, J. Ledbetter, P. Mcgowan, P. Linsley (1992)
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4Cell, 71
N. Damle, K. Klussman, G. Leytze, S. Myrdal, A. Aruffo, J. Ledbetter, P. Linsley (1994)
Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.Journal of immunology, 152 6
N. Perico, O. Imberti, M. Bontempelli, G. Remuzzi (1995)
Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4Ig.Kidney international, 47 1
Sylvia Guerder, D. Picarella, Peter LINSLEYt, R. Flavell (1994)
Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice.Proceedings of the National Academy of Sciences of the United States of America, 91 11
R. Peach, Jürgen Bajorath, W. Brady, G. Leytze, JoAnne Greene, J. Naemura, P. Linsley (1994)
Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1The Journal of Experimental Medicine, 180
D. Lenschow, Stephen Ho, I. Sattar, L. Rhee, G. Gray, N. Nabavi, K. Herold, J. Bluestone (1995)
Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouseThe Journal of Experimental Medicine, 181
S. Sheldon, P. Hasleton, Ali Rhaman, A. Deiraniya, C. Campbell, N. Brooks, P. Dyer (1994)
REJECTION IN HEART TRANSPLANTATION STRONGLY CORRELATES WITH HLA‐DR ANTIGEN MISMATCHTransplantation, 58
Pin Lu, Xia Zhou, S.-J. Chen, Mark Moorman, S. Morris, F. Finkelman, Peter Linsley, Joseph Urban, W. Gause (1994)
CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasiteThe Journal of Experimental Medicine, 180
P. Wallace, J. Johnson, J. Macmaster, K. Kennedy, P. Gladstone, P. Linsley (1994)
CTLA4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers.Transplantation, 58 5
Elizabeth Kearney, K. Pape, D. Loh, M. Jenkins (1994)
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.Immunity, 1 4
A. Vallé, J. Aubry, I. Durand, J. Banchereau (1991)
IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T cell CD28: an amplification mechanism for T-B cell interactions.International immunology, 3 3
C. Larsen, Shannon Kitchie, T. Pearson, P. Linsley, R. Lowry (1992)
Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populationsThe Journal of Experimental Medicine, 176
M. Roy, A. Aruffo, J. Ledbetter, P. Linsley, M. Kehry, R. Noelle (1995)
Studies on the interdependence of gp39 and B7 expression and function during antigen‐specific immune responsesEuropean Journal of Immunology, 25
T. Pearson, D. Alexander, K. Winn, Peter Linsley, Robin Lowry, Christian Larsen (1994)
Transplantation tolerance induced by CTLA4-Ig.Transplantation, 57 12
G. Freeman, David Lombard, Claude Gimmi, S. Brod, Kelvin Lee, J. Laning, David Hafler, Martin Dorf, G. Gray, Hans Reiser, Carl June, Craig Thompson, Lee Nadler (1992)
CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.Journal of immunology, 149 12
James McArthur, D. Raulet (1993)
CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4The Journal of Experimental Medicine, 178
M. Sayegh, E. Akalin, W. Hancock, M. Russell, C. Carpenter, P. Linsley, L. Turka (1995)
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2The Journal of Experimental Medicine, 181
T. Pouw‐Kraan, C. Kooten, I. Rensink, L. Aarden (1992)
Interleukin (IL)‐4 production by human T cells: differential regulation of IL‐4 vs. IL‐2 productionEuropean Journal of Immunology, 22
Hua Lin, S. Bolling, P. Linsley, R. Wei, D. Gordon, C. Thompson, L. Turka (1993)
Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusionThe Journal of Experimental Medicine, 178
Jane Gross, Jane Gross, Eleni Callas, James Allison (1992)
Identification and distribution of the costimulatory receptor CD28 in the mouse.Journal of immunology, 149 2
F. Durie, T. Foy, S. Masters, J. Laman, R. Noelle (1994)
The role of CD40 in the regulation of humoral and cell-mediated immunity.Immunology today, 15 9
G. Freeman, Hans Reiser, John Ng, Jinny Kim, John Goldberg, K. Hathcock, Glória László, Lisa Lombard, Sophia Wang, Gary Gray, Lee Nadler, Arlene Sharpe (1993)
Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 productionThe Journal of Experimental Medicine, 178
P. Linsley, JoAnne Greene, Patrick Tan, J. Bradshaw, J. Ledbetter, Claudio Anasetti, N. Damle (1992)
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytesThe Journal of Experimental Medicine, 176
P. Lane, C. Burdet, S. Hubele, D. Scheidegger, Urs Mfiller, Fiona McConne, M. Kosco-Vilbois (1994)
B cell function in mice transgenic for mCTLA4-H gamma 1: lack of germinal centers correlated with poor affinity maturation and class switching despite normal priming of CD4+ T cellsThe Journal of Experimental Medicine, 179
F. Willems, A. Marchant, J. Delville, C. Gerard, A. Delvaux, T. Velu, M. Boer, M. Goldman (1994)
Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytesEuropean Journal of Immunology, 24
K. Harper, C. Balzano, E. Rouvier, M. Mattei, M. Luciani, P. Golstein (1991)
CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location.Journal of immunology, 147 3
G. Freeman, V. Boussiotis, A. Anumanthan, Gregory Bernstein, Xiao Ke, P. Rennert, G. Gray, John Grlbben, L. Nadler (1995)
B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4.Immunity, 2 5
M. Boer, A. Kasran, J. Kwekkeboom, H. Walter, P. Vandenberghe, J. Ceuppens (1993)
Ligation of B7 with CD28/CTLA‐4 on T cells results in CD40 ligand expression, interleukin‐4 secretion and efficient help for antibody production by B cellsEuropean Journal of Immunology, 23
K. Nishikawa, P. Linsley, A. Collins, I. Stamenkovic, R. McCluskey, G. Andres (1994)
Effect of CTLA‐4 chimeric protein on rat autoimmune anti‐glomerular basement membrane glomerulonephritisEuropean Journal of Immunology, 24
Lieping Chen, P. Mcgowan, S. Ashe, Janet Johnston, Yiwen Li, I. Hellstrom, K. Hellström (1994)
Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunityThe Journal of Experimental Medicine, 179
Laurence Turka, J. Ledbetter, Kelvin Lee, C. June, C. Thompson (1990)
CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.Journal of immunology, 144 5
T. Yokochi, R. Holly, E. Clark (1982)
B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.Journal of immunology, 128 2
D. Lenschow, Anne Sperling, Michael Cooke, G. Freeman, Lesley Rhee, D. Decker, Gary Gray, Lee Nadler, Christopher Goodnow, J. Bluestone (1994)
Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen.Journal of immunology, 153 5
P. Linsley, E. Clark, J. Ledbetter (1990)
T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.Proceedings of the National Academy of Sciences of the United States of America, 87 13
M. Das, S. Zamvil, F. Borriello, H. Weiner, A. Sharpe, V. Kuchroo (1995)
Reciprocal expression of co‐stimulatory molecules, B7‐1 and B7‐2, on murine T cells following activationEuropean Journal of Immunology, 25
N. Nabavi, G. Freeman, A. Gault, Dale Godfrey, L. Nadler, Laurie Glimcher (1992)
Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expressionNature, 360
A. Freedman, G. Freeman, K. Rhynhart, L. Nadler (1991)
Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway.Cellular immunology, 137 2
M. Krummel, J. Allison (1995)
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulationThe Journal of Experimental Medicine, 182
KEI-ICHI Nakayama, I. Negishi, K. Kuida, Yoichi Shinkai, Marjorie Louie, L. Fields, PJ Lucas, Valerie Stewart, Frederick Alt (1993)
Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice.Science, 261 5128
J. Brunet, F. Denizot, M. Luciani, M. Roux-Dosseto, M. Suzan, M. Mattei, P. Golstein (1987)
A new member of the immunoglobulin superfamily—CTLA-4Nature, 328
S. Townsend, Fannie Su, J. Atherton, J. Allison (1994)
Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.Cancer research, 54 24
G. Freeman, A. Freedman, Jeff Segil, G. Lee, J. Whitman, L. Nadler (1989)
B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.Journal of immunology, 143 8
Shuhua Han, K. Hathcock, B. Zheng, T. Kepler, R. Hodes, G. Kelsoe (1995)
Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers.Journal of immunology, 155 2
G. Freeman, J. Gribben, V. Boussiotis, Judy Ng, Vincent Restivo, Lisa Lombard, G. Gray, L. Nadler (1993)
Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.Science, 262 5135
Sylvie Guarder, Sylvie Guarder, Jeffrey Meyerhoff, R. Flavell, R. Flavell (1994)
The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen.Immunity, 1 2
Guchen Yang, K. Hellstrom, I. Hellström, Lieping Chen (1995)
Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules.Journal of immunology, 154 6
P. Perrin, Dorothy Scott, Laura Quigley, Paul Albert, O. Feder, Gary Gray, Ryo Abe, Carl June, M. Racke (1995)
Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis.Journal of immunology, 154 3
C. Chen, N. Nabavi (1994)
In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2.Immunity, 1 2
S. Townsend, J. Allison (1993)
Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.Science, 259 5093
F. Cavallo, A. Martín-Fontecha, M. Bellone, S. Heltai, E. Gatti, P. Tornaghi, M. Freschi, G. Forni, P. Dellabona, G. Casorati (1995)
Co‐expression of B7‐1 and ICAM‐1 on tumors is required for rejection and the establishment of a memory responseEuropean Journal of Immunology, 25
Z. Razi‐Wolf, F. Galvin, G. Gray, H. Reiser (1993)
Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor.Proceedings of the National Academy of Sciences of the United States of America, 90 23
P. Tan, C. Anasetti, J. Hansen, J. Melrose, M. Brunvand, J. Bradshaw, J. Ledbetter, P. Linsley (1993)
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1The Journal of Experimental Medicine, 177
P. Linsley, JoAnne Greene, W. Brady, Jürgen Bajorath, J. Ledbetter, R. Peach (1994)
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.Immunity, 1 9
C. June, J. Bluestone, L. Nadler, C. Thompson (1994)
The B7 and CD28 receptor families.Immunology today, 15 7
L. Ding, P. Linsley, Li-Yun Huang, Ronald Germain, E. Shevach (1993)
IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.Journal of immunology, 151 3
V. Kuchroo, M. Das, Julia Brown, A. Ranger, S. Zamvil, R. Sobel, H. Weiner, N. Nabavi, L. Glimcher (1995)
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapyCell, 80
C. Chen, D. Faherty, A. Gault, S. Connaughton, G. Powers, D. Godfrey, N. Nabavi (1994)
Monoclonal antibody 2D10 recognizes a novel T cell costimulatory molecule on activated murine B lymphocytes.Journal of immunology, 152 5
Yiwen Li, P. Mcgowan, I. Hellstrom, K. Hellström, Lieping Chen (1994)
Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.Journal of immunology, 153 1
Carl June, Jeffrey Ledbetter, P. Linsley, C. Thompson (1990)
Role of the CD28 receptor in T-cell activation.Immunology today, 11 6
▪ Abstract T cells play a central role in the initiation and regulation of the immune response to antigen. Both the engagement of the TCR with MHC/Ag and a second signal are needed for the complete activation of the T cell. The CD28/B7 receptor/ligand system is one of the dominant costimulatory pathways. Interruption of this signaling pathway with CD28 antagonists not only results in the suppression of the immune response, but in some cases induces antigen-specific tolerance. However, the CD28/B7 system is increasingly complex due to the identification of multiple receptors and ligands with positive and negative signaling activities. This review summarizes the state of CD28/B7 immunobiology both in vitro and in vivo; summarizes the many experiments that have led to our current understanding of the participants in this complex receptor/ligand system; and illustrates the current models for CD28/B7-mediated T cell and B cell regulation. It is our hope and expectation that this review will provoke additional research that will unravel this important, yet complex, signaling pathway.
Annual Review of Immunology – Annual Reviews
Published: Apr 1, 1996
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.